Evidence map›Paper›PMID 35431943›Full record

ArticleFrontiers in pharmacology2022

Establishment and Optimization of Radiomics Algorithms for Prediction of KRAS Gene Mutation by Integration of NSCLC Gene Mutation Mutual Exclusion Information.

Jingyi Wang, Xing Lv, Weicheng Huang, Zhiyong Quan, Guiyu Li, Shuo Wu, Yirong Wang, Zhaojuan Xie, Yuhao Yan, Xiang Li and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Predictive value ofFrontiers in oncology · 2024
    Pooled it
  4. Article
  5. Review
  6. Radiogenomics-based prediction ofZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Jingyi WangDepartment of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Xing LvDepartment of Respiratory Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Weicheng HuangSchool of Information Science and Technology, Northwest University, Xi'an, China.
Zhiyong QuanDepartment of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Guiyu LiDepartment of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Shuo WuDepartment of Respiratory Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Yirong WangDepartment of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Zhaojuan XieDepartment of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Yuhao YanDepartment of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Xiang LiDepartment of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Wenhui MaDepartment of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Weidong YangDepartment of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Xin CaoSchool of Information Science and Technology, Northwest University, Xi'an, China.
Fei KangDepartment of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Jing WangDepartment of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Xijing Hospital · CNNorthwest University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EGFRKRASnon-small cell lung cancerPET/CTradiomics

Identifiers

PMID35431943
PMCPMC9010886
OpenAlexW4220735753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.